This site is intended for healthcare professionals only

DiabetesontheNet Logo
×

Journal of
Diabetes Nursing

Issue:

Share this article
Share on facebook
Share on twitter
Share on email
Share on print

JBDS-IP seeks feedback on VRIII use in the hospital setting

Audit will be used to update the JBDS-IP guideline on VRIII use.

The Joint British Diabetes Societies for Inpatient Care (JBDS-IP) have launched new audit on the use of variable-rate intravenous insulin infusions (VRIIIs). Healthcare professionals including Diabetes Specialist Nurses are being asked to complete a questionnaire on how they used VRIIIs on people with diabetes who were admitted to hospital.

The JBDS-IP will use the feedback to update its VRIII guideline, which dates back to October 2014 and aims to guide non-specialist teams in the appropriate and safe use of a VRIII.

The audit is open until Friday 24th December 2021. Note that patients in whom VRIII was started due to diabetic ketoacidosis, hyperosmolar hyperglycaemic state or COVID-19 infection should not be included.

Click here to complete the audit.

Share this article
Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on whatsapp
Related content
For the latest news and articles

Sign up to all DiabetesontheNet journals

© Copyright Omniamed Communications. All Rights Reserved​
108 Cannon Street, London, EC4N 6EU. Registered in the United Kingdom​
Omniamed logo white
DiabetesontheNet Logo
For the latest news and articles

Sign up to all DiabetesontheNet journals

 

By clicking ‘Subscribe’, you are agreeing that DiabetesontheNet.com are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our Privacy Policy.

DiabetesontheNet Logo

This website is for UK healthcare professionals only. To continue, please confirm that you are a UK healthcare professional below.